Transcriptional activation of the utrophin promoter B by a constitutively active Ets-transcription factor

Neuromuscular Disorders

Volumn 13, Issue 2, 2003, Pages 143-150

  Briguet, Alexandre ^a   Bleckmann, Dorothee ^a   Bettan, Mickaël ^b   Mermod, Nicolas ^b   Meier, Thomas ^a  

^a MyoContract Ltd   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Duchenne muscular dystrophy; GA binding protein; Utrophin

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; GA BINDING PROTEIN BETA; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA CHAIN; CONTROLLED STUDY; DNA MODIFICATION; DNA TRANSFER; ELECTROTRANSFORMATION; GENE ACTIVATION; MOUSE; MUSCLE; MUSCLE CELL; MUSCLE INNERVATION; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0037306405     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00217-1     Document Type: Article

References (39)

1. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 50:1987;509-517.
2. Tinsley J.M., Potter A.C., Phelps S.R., Fisher R., Trickett J.I., Davies K.E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature. 384:1996;349-353.
3. Deconinck N., Tinsley J., De Backer F., et al. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat Med. 3:1997;1216-1221.
4. Rafael J.A., Tinsley J.M., Potter A.C., Deconinck A.E., Davies K.E. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat Genet. 19:1998;79-82.
5. Tinsley J., Deconinck N., Fisher R., et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med. 4:1998;1441-1444.
6. Gilbert R., Nalbantoglu J., Petrof B.J., et al. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther. 10:1999;1299-1310.
7. Gramolini A.O., Belanger G., Jasmin B.J. Distinct regions in the 3′ untranslated region are responsible for targeting and stabilizing utrophin transcripts in skeletal muscle cells. J Cell Biol. 154:2001;1173-1183.
8. Jasmin B.J., Angus L.M., Belanger G., et al. Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers: insights into a therapeutic strategy for Duchenne muscular dystrophy. J Physiol (Paris). 96:2002;31-42.
9. Dennis C.L., Tinsley J.M., Deconinck A.E., Davies K.E. Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res. 24:1996;1646-1652.
10. Gramolini A.O., Angus L.M., Schaeffer L., et al. Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proc Natl Acad Sci USA. 96:1999;3223-3227.
11. Burton E.A., Tinsley J.M., Holzfeind P.J., Rodrigues N.R., Davies K.E. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proc Natl Acad Sci USA. 96:1999;14025-14030.
12. LaMarco K., Thompson C.C., Byers B.P., Walton E.M., McKnight S.L. Identification of Ets- and notch-related subunits in GA binding protein [see comments]. Science. 253:1991;789-792.
13. Thompson C.C., Brown T.A., McKnight S.L. Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex [see comments]. Science. 253:1991;762-768.
14. Brown T.A., McKnight S.L. Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ets-related proteins. Genes Dev. 6:1992;2502-2512.
15. Sawa C., Goto M., Suzuki F., Watanabe H., Sawada J., Handa H. Functional domains of transcription factor hGABP beta1/E4TF1-53 required for nuclear localization and transcription activation. Nucleic Acids Res. 24:1996;4954-4961.
16. Fromm L., Burden S.J. Synapse-specific and neuregulin-induced transcription require an ets site that binds GABPalpha/GABPbeta. Genes Dev. 12:1998;3074-3083.
17. Schaeffer L., Duclert N., Huchet-Dymanus M., Changeux J.P. Implication of a multisubunit Ets-related transcription factor in synaptic expression of the nicotinic acetylcholine receptor. EMBO J. 17:1998;3078-3090.
18. Briguet A., Ruegg M.A. The Ets transcription factor GABP is required for postsynaptic differentiation in vivo. J Neurosci. 20:2000;5989-5996.
19. Gramolini A.O., Angus L.M., Schaeffer L., et al. Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proc Natl Acad Sci USA. 96:1999;3223-3227.
20. Khurana T.S., Rosmarin A.G., Shang J., Krag T.O., Das S., Gammeltoft S. Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta. Mol Biol Cell. 10:1999;2075-2086.
21. Fromm L., Burden S.J. Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells. Biochemistry. 40:2001;5306-5312.
22. Triezenberg S.J., Kingsbury R.C., McKnight S.L. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 2:1988;718-729.
23. Jaynes J.B., Johnson J.E., Buskin J.N., Gartside C.L., Hauschka S.D. The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol Cell Biol. 8:1988;62-70.
24. Barton C.H., Mann D.A., Walsh F.S. Characterization of the human N-CAM promoter. Biochem J. 268:1990;161-168.
25. Abicht A., Stucka R., Schmidt C., et al. A newly identified chromosomal microdeletion and an N-box mutation of the AChRepsilon gene cause a congenital myasthenic syndrome. Brain. 125:2002;1005-1013.
26. Mir L.M., Bureau M.F., Gehl J., et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA. 96:1999;4262-4267.
27. Bettan M., Emmanuel F., Darteil R., et al. High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther. 2:2000;204-210.
28. Schaeffer L., de Kerchove d'Exaerde A., Changeux J.P. Targeting transcription to the neuromuscular synapse. Neuron. 31:2001;15-22.
29. Duclert A., Savatier N., Schaeffer L., Changeux J.P. Identification of an element crucial for the sub-synaptic expression of the acetylcholine receptor epsilon-subunit gene. J Biol Chem. 271:1996;17433-17438.
30. Stringer K.F., Ingles C.J., Greenblatt J. Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature. 345:1990;783-786.
31. Goodrich J.A., Hoey T., Thut C.J., Admon A., Tjian R. Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell. 75:1993;519-530.
32. Roberts S.G., Ha I., Maldonado E., Reinberg D., Green M.R. Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation. Nature. 363:1993;741-744.
33. Xiao H., Pearson A., Coulombe B., et al. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol. 14:1994;7013-7024.
34. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
35. Duclert A., Changeux J.P. Acetylcholine receptor gene expression at the developing neuromuscular junction. Physiol Rev. 75:1995;339-368.
36. Batchelor A.H., Piper D.E., de la Brousse F.C., McKnight S.L., Wolberger C. The structure of GABPalpha/beta: an ETS domain- ankyrin repeat heterodimer bound to DNA. Science. 279:1998;1037-1041.
37. Smith C.L., Hager G.L. Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J Biol Chem. 272:1997;27493-27496.
38. Beato M., Eisfeld K. Transcription factor access to chromatin. Nucleic Acids Res. 25:1997;3559-3563.
39. Reik A., Gregory P.D., Urnov F.D. Biotechnologies and therapeutics: chromatin as a target. Curr Opin Genet Dev. 12:2002;233-242.